Adult Repetitive Behaviors Questionnaire-2 (RBQ-2A): A self-administered questionnaire that measures restricted and repetitive behaviors in adults
That guides whether ongoing injections or oral therapy is best
BPC-157 may influence dopamine and serotonin regulation, supporting mood balance and stress tolerance
Protect from Light Dark Container : Store BPC 157 in its original dark vial or another opaque container to protect it from light exposure, which can degrade the peptide
Additional testing for endotoxins, heavy metals, and microbial contamination ensures the product meets pharmaceutical-grade standards
(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)
